Artbio in a $132 million Series B deal co-led by Sofinnova Investments and B Capital, joined by F-Prime, Omega Funds, and Third Rock Ventures.
05 July 2025
05 July 2025
Total investments received (USD): 245M
Round value (USD): 132M
Company: Artbio
Related deals
Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.
Investments
07 November 2025
Distalmotion raises $150M series G with Revival Healthcare Capital
Investments
06 November 2025
ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion
M&A
12 October 2025
Adcytherix raised €105m in Series A from Andera Partners, Angelini Ventures, Kurma Partners, Surveyor Capital, aMoon, Pontifax, DawnBiopharma, RA Capital.
Investments
03 October 2025
OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion
Secondary
14 July 2025
Belgium
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Ireland
Portugal
Spain